PCSK9 and neoplasm: Treating of PDAC cells with recombinant protein or neutralizing antibody revealed that Pcsk9, but not PGRN, increased PDAC proliferation under glucose-limiting conditions, indicating the role of Pcsk9 in regulating tumor growth (Fig. 6k, l).